We are happy to see that Nanolive imaging has been used to confirm the success of another new therapy, this time treating melasma. In their latest paper “Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved in melasma pathophysiology”, mesoestetic’s Biotechnology Unit published Nanolive refractive index images of treated and untreated melanocytes1.
Thanks to the high refractive index values of melanin granules, they could be clearly imaged label-free, using the Nanolive platform. Indeed, the images clearly showed that mesoestetic’s treatment decreased the number of melanin granules in melanocytes, which will translate to decreased pigmentation of melasmas in patient skin.
“Nanolive technology has been very useful in order to study the effect of our compounds on melanocytes with high resolution. Live-cell imaging allowed us to see how morphology and melanosomes accumulation changed in real time with the treatment, providing clear evidence of the in vitro efficacy of these compounds.”
Mesoestetic is a pharmaceutical company leading the development and production of therapies in dermatology and aesthetic medicine. You can read their paper in full here.
References:
(1) Alfredo, M.-G.; Maribel, P.-M.; Eloy, P.-R.; Susana, G.-E.; Shotze, L. G.; Carmen, G. M. Depigmenting Topical Therapy Based on a Synergistic Combination of Compounds Targeting the Key Pathways Involved in Melasma Pathophysiology. Experimental Dermatology. https://doi.org/10.1111/exd.14752 .
Read our latest news
Mitochondrial secretion captured by Nanolive’s live cell imaging in new Cell Metabolism Paper
Congratulations to scientists at Seoul National University who have recently published their work in Cell Metabolism in their article “Mitochondrial fragmentation and donut formation enhance mitochondrial secretion to promote osteogenesis”! The authors characterized...
Nanolive revolutionizing mitochondrial therapy research in Japan: “Seeing is believing”
Nanolive installed the CX-A automated live cell imaging platform at LUCA Science in Sapporo, Japan Nanolive SA announced today the installation of their CX-A imaging platform at LUCA Science’s Research & Development Center in Sapporo, Japan. LUCA Science is...
Towards a therapy to reduce damage after traumatic brain injury with Nanolive solutions
The Roselli Lab at the University of Ulm have been researching potential avenues to reduce neuronal death after traumatic brain injury, and uncovered a key role for interleukin-13, published in Nature Communications this month (Interleukin-13 and its receptor are...
